Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-05-30 Sale |
2023-06-01 5:44 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $64.88 | $1,621,894 | 466,959 (Direct) |
View |
| 2023-04-25 Sale |
2023-04-27 5:37 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $50.67 | $1,266,638 | 491,959 (Direct) |
View |
| 2023-03-29 Sale |
2023-03-31 5:49 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $44.46 | $1,111,504 | 516,959 (Direct) |
View |
| 2023-02-27 Sale |
2023-03-01 6:11 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $48.25 | $1,206,243 | 530,570 (Direct) |
View |
| 2023-01-27 Sale |
2023-01-31 5:34 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $51.47 | $1,286,798 | 548,693 (Direct) |
View |
| 2022-12-28 Sale |
2022-12-30 5:33 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $40.93 | $1,023,290 | 573,693 (Direct) |
View |
| 2022-11-28 Sale |
2022-11-30 5:36 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $54.03 | $1,350,827 | 519,861 (Direct) |
View |
| 2022-10-26 Sale |
2022-10-28 5:43 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $54.81 | $1,370,191 | 558,612 (Direct) |
View |
| 2022-09-28 Sale |
2022-09-30 5:42 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $64.61 | $1,615,160 | 323,612 (Direct) |
View |
| 2022-08-29 Sale |
2022-08-31 5:45 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $66.84 | $1,671,084 | 348,612 (Direct) |
View |
| 2022-07-27 Sale |
2022-07-29 5:38 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $75.91 | $1,897,747 | 373,612 (Direct) |
View |
| 2022-06-29 Sale |
2022-07-01 6:00 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $61.59 | $1,539,862 | 298,612 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-08 Option Award |
2023-06-09 5:36 pm |
N/A 2033-06-08 |
CRISPR Therapeutics AG | CRSP | High Katherine A Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-09 5:34 pm |
N/A 2033-06-08 |
CRISPR Therapeutics AG | CRSP | Greene John Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-09 5:34 pm |
N/A 2033-06-08 |
CRISPR Therapeutics AG | CRSP | Fleming Harold Edward Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-09 5:33 pm |
N/A 2033-06-08 |
CRISPR Therapeutics AG | CRSP | Fardis Maria Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2023-05-30 Exercise |
2023-06-01 5:44 pm |
N/A 2027-12-01 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 466,959 (Direct) |
View |
| 2023-05-30 Exercise |
2023-06-01 5:44 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $19.12 | 466,959 (Direct) |
View |
| 2023-05-23 Exercise |
2023-05-25 5:35 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Morrow Phuong Khanh Chief Medical Officer |
6,938 | $0 | 25,223 (Direct) |
View |
| 2023-05-24 Tax Withholding |
2023-05-25 5:35 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Morrow Phuong Khanh Chief Medical Officer |
2,527 | $65.91 | 25,223 (Direct) |
View |
| 2023-04-25 Exercise |
2023-04-27 5:37 pm |
N/A 2027-12-01 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 491,959 (Direct) |
View |
| 2023-04-25 Exercise |
2023-04-27 5:37 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $19.12 | 491,959 (Direct) |
View |
| 2023-03-29 Exercise |
2023-03-31 5:49 pm |
N/A 2027-12-01 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 516,959 (Direct) |
View |
| 2023-03-29 Exercise |
2023-03-31 5:49 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $19.12 | 516,959 (Direct) |
View |
| 2023-03-14 Option Award |
2023-03-14 5:50 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Prasad Raju Chief Financial Officer |
140,000 | $0 | 140,000 (Direct) |
View |
| 2023-03-10 Exercise |
2023-03-14 5:47 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
20,833 | $0 | 670,377 (Direct) |
View |
| 2023-03-13 Tax Withholding |
2023-03-14 5:47 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
9,444 | $43.22 | 670,377 (Direct) |
View |
| 2023-03-10 Option Award |
2023-03-14 5:47 pm |
N/A 2033-03-10 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
265,000 | $0 | 670,377 (Direct) |
View |
| 2023-03-10 Exercise |
2023-03-14 5:45 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
5,083 | $0 | 121,344 (Direct) |
View |
| 2023-03-13 Tax Withholding |
2023-03-14 5:45 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
2,305 | $43.22 | 121,344 (Direct) |
View |
| 2023-03-10 Option Award |
2023-03-14 5:45 pm |
N/A 2033-03-10 |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
62,000 | $0 | 121,344 (Direct) |
View |
| 2023-03-10 Option Award |
2023-03-14 5:44 pm |
N/A 2033-03-10 |
CRISPR Therapeutics AG | CRSP | Morrow Phuong Khanh Chief Medical Officer |
66,620 | $0 | 66,620 (Direct) |
View |
| 2023-02-27 Exercise |
2023-03-01 6:11 pm |
N/A 2027-12-01 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 530,570 (Direct) |
View |
| 2023-02-27 Exercise |
2023-03-01 6:11 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $19.12 | 530,570 (Direct) |
View |
| 2023-02-18 Exercise |
2023-02-22 5:41 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Smith Brendan Chief Financial Officer |
3,825 | $0 | 16,547 (Direct) |
View |
| 2023-02-21 Tax Withholding |
2023-02-22 5:41 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Smith Brendan Chief Financial Officer |
1,392 | $48.26 | 16,547 (Direct) |
View |
| 2023-02-18 Exercise |
2023-02-22 5:38 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
13,250 | $0 | 415,738 (Direct) |
View |
| 2023-02-21 Tax Withholding |
2023-02-22 5:38 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
6,373 | $48.26 | 415,738 (Direct) |
View |
| 2023-02-18 Exercise |
2023-02-22 5:35 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
3,825 | $0 | 63,541 (Direct) |
View |
| 2023-02-21 Tax Withholding |
2023-02-22 5:35 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
1,950 | $48.26 | 63,541 (Direct) |
View |
| 2023-01-27 Exercise |
2023-01-31 5:34 pm |
N/A 2027-12-01 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 548,693 (Direct) |
View |
| 2023-01-27 Exercise |
2023-01-31 5:34 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $19.12 | 548,693 (Direct) |
View |
| 2022-12-28 Exercise |
2022-12-30 5:33 pm |
N/A 2027-12-01 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 573,693 (Direct) |
View |
| 2022-12-28 Exercise |
2022-12-30 5:33 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $19.12 | 573,693 (Direct) |
View |
| 2022-12-06 Exercise |
2022-12-08 5:35 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
58,233 | $0 | 369,111 (Direct) |
View |
| 2022-12-06 Exercise |
2022-12-08 5:35 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
58,233 | $1.81 | 369,111 (Direct) |
View |
| 2022-12-03 Exercise |
2022-12-06 5:49 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
40,000 | $0 | 310,878 (Direct) |
View |
| 2022-12-05 Tax Withholding |
2022-12-06 5:49 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
19,401 | $52.26 | 310,878 (Direct) |
View |
| 2022-12-03 Exercise |
2022-12-06 5:47 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
6,667 | $0 | 50,191 (Direct) |
View |
| 2022-12-05 Tax Withholding |
2022-12-06 5:47 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
3,234 | $52.26 | 50,191 (Direct) |
View |
| 2022-11-28 Exercise |
2022-11-30 5:36 pm |
N/A 2027-12-01 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 519,861 (Direct) |
View |
| 2022-11-28 Exercise |
2022-11-30 5:36 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $19.12 | 519,861 (Direct) |
View |
| 2022-10-26 Exercise |
2022-10-28 5:43 pm |
N/A 2027-05-03 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 558,612 (Direct) |
View |
| 2022-10-26 Exercise |
2022-10-28 5:43 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
19,582 | $16.21 | 558,612 (Direct) |
View |
| 2022-10-26 Exercise |
2022-10-28 5:43 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
5,418 | $19.12 | 558,612 (Direct) |
View |
| 2022-10-14 Exercise |
2022-10-18 5:38 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Smith Brendan Chief Financial Officer |
3,750 | $0 | 13,889 (Direct) |
View |
| 2022-10-17 Tax Withholding |
2022-10-18 5:38 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Smith Brendan Chief Financial Officer |
1,111 | $55.76 | 13,889 (Direct) |
View |
| 2022-10-07 Option Award |
2022-10-12 5:42 pm |
N/A 2032-10-07 |
CRISPR Therapeutics AG | CRSP | Smith Brendan Chief Financial Officer |
14,000 | $0 | 14,000 (Direct) |
View |
| 2022-10-07 Option Award |
2022-10-12 5:41 pm |
N/A 2032-10-07 |
CRISPR Therapeutics AG | CRSP | Morrow Phuong Khanh Chief Medical Officer |
9,380 | $0 | 9,380 (Direct) |
View |
| 2022-10-07 Option Award |
2022-10-12 5:40 pm |
N/A 2032-10-07 |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
14,000 | $0 | 14,000 (Direct) |
View |
| 2022-09-28 Exercise |
2022-09-30 5:42 pm |
N/A 2027-05-03 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 323,612 (Direct) |
View |
| 2022-09-28 Exercise |
2022-09-30 5:42 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $16.21 | 323,612 (Direct) |
View |
| 2022-08-29 Exercise |
2022-08-31 5:45 pm |
N/A 2027-05-03 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 348,612 (Direct) |
View |
| 2022-08-29 Exercise |
2022-08-31 5:45 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $16.21 | 348,612 (Direct) |
View |
| 2022-08-16 Option Award |
2022-08-18 5:39 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Smith Brendan Chief Financial Officer |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-08-16 Option Award |
2022-08-18 5:37 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
175,000 | $0 | 175,000 (Direct) |
View |
| 2022-08-16 Option Award |
2022-08-18 5:36 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
12,500 | $0 | 12,500 (Direct) |
View |
| 2022-08-16 Option Award |
2022-08-18 5:33 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-07-27 Exercise |
2022-07-29 5:38 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
8,333 | $12.57 | 373,612 (Direct) |
View |
| 2022-07-27 Exercise |
2022-07-29 5:38 pm |
N/A 2026-07-15 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 373,612 (Direct) |
View |
| 2022-07-27 Exercise |
2022-07-29 5:38 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
16,667 | $16.21 | 373,612 (Direct) |
View |
| 2022-06-29 Exercise |
2022-07-01 6:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $12.57 | 298,612 (Direct) |
View |
| 2022-06-29 Exercise |
2022-07-01 6:00 pm |
N/A 2026-07-15 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 298,612 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:46 pm |
N/A 2032-06-09 |
CRISPR Therapeutics AG | CRSP | Behbahani Ali Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:44 pm |
N/A 2032-06-09 |
CRISPR Therapeutics AG | CRSP | Treco Douglas A Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:43 pm |
N/A 2032-06-09 |
CRISPR Therapeutics AG | CRSP | High Katherine A Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:41 pm |
N/A 2032-06-09 |
CRISPR Therapeutics AG | CRSP | Greene John Director |
12,000 | $0 | 12,000 (Direct) |
View |